User profiles for "author:Spyridon Deftereos"
Spyridon DeftereosNational and Kapodistrian University of Athens, Medical School Verified email at med.uoa.gr Cited by 22737 |
Colchicine in cardiovascular disease: in-depth review
SG Deftereos, FJ Beerkens, B Shah, G Giannopoulos… - Circulation, 2022 - Am Heart Assoc
Inflammation plays a prominent role in the development of atherosclerosis and other
cardiovascular diseases, and anti-inflammatory agents may improve cardiovascular …
cardiovascular diseases, and anti-inflammatory agents may improve cardiovascular …
Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials
Current recommendations do not specifically address the optimal blood pressure (BP)
reduction for secondary stroke prevention in patients with previous cerebrovascular events …
reduction for secondary stroke prevention in patients with previous cerebrovascular events …
Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease
N Anatoliotakis, S Deftereos, G Bouras… - Current topics in …, 2013 - ingentaconnect.com
Myeloperoxidase (MPO), a heme protein released by leukocytes, is one of the most widely
studied during the last decades molecule that plays a crucial role in inflammation and …
studied during the last decades molecule that plays a crucial role in inflammation and …
2019 ESC guidelines for the management of patients with supraventricular tachycardia the task force for the management of patients with supraventricular tachycardia …
J Brugada, DG Katritsis, E Arbelo, F Arribas… - European heart …, 2020 - academic.oup.com
Supraventricular arrhythmias are common and patients are often symptomatic, requiring
management with drugs and electrophysiological procedures. The ESC published …
management with drugs and electrophysiological procedures. The ESC published …
Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the …
Importance Severe acute respiratory syndrome coronavirus 2 infection has evolved into a
global pandemic. Low-dose colchicine combines anti-inflammatory action with a favorable …
global pandemic. Low-dose colchicine combines anti-inflammatory action with a favorable …
[HTML][HTML] Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre …
JC Tardif, N Bouabdallaoui, PL L'allier… - The Lancet …, 2021 - thelancet.com
Background Evidence suggests a role for excessive inflammation in COVID-19
complications. Colchicine is an oral anti-inflammatory medication beneficial in gout …
complications. Colchicine is an oral anti-inflammatory medication beneficial in gout …
Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action
I Rentoukas, G Giannopoulos, A Kaoukis… - JACC: Cardiovascular …, 2010 - jacc.org
Objectives: We sought to determine the potential of remote ischemic periconditioning
(RIPC), and its combination with morphine, to reduce reperfusion injury in primary …
(RIPC), and its combination with morphine, to reduce reperfusion injury in primary …
Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study
S Deftereos, G Giannopoulos, C Angelidis… - Circulation, 2015 - Am Heart Assoc
Background—Inflammatory processes have been identified as key mediators of the
deleterious effects of ischemia/reperfusion in ST-segment–elevation myocardial infarction …
deleterious effects of ischemia/reperfusion in ST-segment–elevation myocardial infarction …
Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study
S Deftereos, G Giannopoulos, C Kossyvakis… - Journal of the American …, 2012 - jacc.org
Objectives: The purpose of the present study was to test the potential of colchicine, an agent
with potent anti-inflammatory action, to reduce atrial fibrillation (AF) recurrence after …
with potent anti-inflammatory action, to reduce atrial fibrillation (AF) recurrence after …
Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients
S Deftereos, G Giannopoulos, K Raisakis… - Journal of the American …, 2013 - jacc.org
Objectives: This study sought to test the hypothesis that colchicine treatment after
percutaneous coronary intervention (PCI) can lead to a decrease in in-stent restenosis (ISR) …
percutaneous coronary intervention (PCI) can lead to a decrease in in-stent restenosis (ISR) …